Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

High doses of radiation found to be effective, with few side effects

21.10.2003


New research shows that men with clinically localized prostate cancer, treated to high dose levels with three-dimensional conformal radiation therapy (3D-CRT), achieved long-term PSA relapse-free survival (PRFS) with minimal side effects. Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) presented findings from the 10-year retrospective study today at the 45th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Salt Lake City, Utah.



"This is the first study that is looking at 10-year results of dose escalation with 3D-CRT and demonstrating improved outcomes in all subgroups of patients treated with high doses of radiation compared to lower conventional dose levels," said the study’s lead author Michael Zelefsky, MD, Chief of MSKCC’s Brachytherapy Service. "We observed that the radiation dose was one of the critical ingredients, or predictors, for achieving improved outcome and enhanced disease control rates in each of the patient groups we evaluated."

Researchers analyzed data from 828 MSKCC patients treated between 1988 and 1997. The patients were categorized into prognostic risk groups based on pre-treatment PSA levels, Gleason score, and clinical stage. At 10 years, the PRFS outcomes for favorable, intermediate, and unfavorable risk patients were 70 percent, 49 percent, and 35 percent respectively. Higher radiation dose levels (the doses in the study ranged from 64.8 Gy up to 75.6 Gy) were associated with an improved PRFS at 10 years for each prognostic group.


The other significant finding of the study is that patients had minimal side effects, despite the fact that higher doses of radiation were delivered. The long-term risk of serious rectal or bladder injuries at 10 years was 2 ½ percent and 1 ½ percent, respectively. "This dispels the notion that as time goes on the side effects become more noticeable and patients are more at risk for developing long-term damage years out from treatment," said Dr. Zelefsky.

"Radiation dose has a significant impact on the outcome of patients with localized prostate cancer treated with radiation therapy. We continue to observe that even higher doses have further improved cure rates for patients with localized prostate cancer," said Steven Leibel, MD, Chairman of MSKCC’s Department of Radiation Oncology and the study’s senior author. "These mature data show that even 10 years from the therapy, despite the application of high radiation doses, the tolerance was excellent."


Memorial Sloan-Kettering Cancer Center is the world’s oldest and largest institution devoted to prevention, patient care, research and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide.

Esther Carver | EurekAlert!
Further information:
http://www.mskcc.org/

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>